6472 — Bora Pharmaceuticals Co Balance Sheet
0.000.00%
Last trade - 00:00
- TWD75.49bn
- TWD79.77bn
- TWD14.20bn
- 96
- 26
- 52
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 543 | 670 | 911 | 3,529 | 3,396 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 346 | 726 | 861 | 6,418 | 4,152 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,246 | 2,627 | 2,792 | 12,241 | 10,603 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,038 | 4,266 | 4,088 | 7,338 | 7,643 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,383 | 7,004 | 7,372 | 22,761 | 25,052 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 557 | 2,286 | 1,841 | 10,496 | 8,229 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,729 | 4,539 | 4,220 | 18,233 | 15,967 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,654 | 2,465 | 3,153 | 4,528 | 9,085 |
Total Liabilities & Shareholders' Equity | 3,383 | 7,004 | 7,372 | 22,761 | 25,052 |
Total Common Shares Outstanding |